Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

Online First

July 04, 2019

Correspondence response
Response to: ‘Impact of Janus kinase inhibitors on the risk of cardiovascular events in patients with rheumatoid arthritis: systematic review and meta-analysis of randomised controlled trials’ by Lee and Song
Free

Wenhui Xie, Shiyu Xiao, Zhuoli Zhang

doi: 10.1136/annrheumdis-2019-215841
Correspondence response
Response to: ‘Can biomarkers differentiate psoriatic arthritis from osteoarthritis?’ by Tian et al
Free

Vinod Chandran, Richard J Cook, Dafna D Gladman

doi: 10.1136/annrheumdis-2019-215762

July 03, 2019

Correspondence response
Response to: ‘Concerns about the operational definition of remission in 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus’ by Rua-Figueroa and Erausquin
Free

Antonis Fanouriakis, George Bertsias, Dimitrios T Boumpas

doi: 10.1136/annrheumdis-2019-215810
Correspondence
Bone health, an often forgotten comorbidity in systemic lupus erythematosus: a comment on the new recommendations
Free

Giovanni Orsolini, Irene Elizabeth Maria Bultink, Giovanni Adami, Angelo Fassio, Ombretta Viapiana, Alessandro Giollo, Davide Gatti, Maurizio Rossini

doi: 10.1136/annrheumdis-2019-215896
Correspondence response
Response to: ‘Comment on editorial ‘Pathogenic effector functions of ACPA: where do we stand’’ by Holmdahl
Free

René Toes, David S Pisetsky

doi: 10.1136/annrheumdis-2019-215870

June 27, 2019

Correspondence response
Response to: ‘Can IL-1 be used as a target for osteoarthritis?’ by Cheng et al
Free

Margreet Kloppenburg, Marc Levesque

doi: 10.1136/annrheumdis-2019-215612

June 22, 2019

Correspondence
Early intensive treatment normalises excess mortality in ACPA-negative RA but not in ACPA-positive RA
Free

Xanthe ME Matthijssen, Tom WJ Huizinga, Ellis Niemantsverdriet, Annette HM van der Helm-van Mil

doi: 10.1136/annrheumdis-2019-215843

June 21, 2019

Correspondence
On using machine learning algorithms to define clinically meaningful patient subgroups
Free

Iago Pinal-Fernandez, Andrew Lee Mammen

doi: 10.1136/annrheumdis-2019-215852
Correspondence
Comment on editorial ‘Pathogenic effector functions of ACPA: where do we stand?’
Free

Rikard Holmdahl

doi: 10.1136/annrheumdis-2019-215857

June 19, 2019

Correspondence response
Response to: ‘Mycophenolate mofetil: a step forward in the induction treatment of ANCA-associated vasculitis? Comment on the article by Jones et al’ by Vandergheynst et al
Free

Rachel B Jones, Thomas F Hiemstra, Michael Walsh, David Jayne, Lorraine Harper

doi: 10.1136/annrheumdis-2019-215658

June 18, 2019

Correspondence
Association between ankylosing spondylitis and venous thromboembolism
Free

Shih-Wei Lai

doi: 10.1136/annrheumdis-2019-215854

June 05, 2019

Correspondence
Treatment of systemic lupus erythematosus: don’t forget hydroxychloroquine
Free

Martin Michaud, Florian Catros, Sophie Ancellin, Francis Gaches

doi: 10.1136/annrheumdis-2019-215799
Correspondence
Concerns about the operational definition of remission in 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
Free

Íñigo Rua Figueroa, Celia Erausquin

doi: 10.1136/annrheumdis-2019-215778
Correspondence response
Antisynthetase antibodies in clinical laboratories: the importance of clinical correlation and indirect immunofluorescence
Free

Martin Greco, Mª Jesus García de Yébenes, Inmaculada Alarcón, Anahy María Brandy-García, Íñigo Rúa-Figueroa, Estibaliz Loza, Loreto Carmona

doi: 10.1136/annrheumdis-2019-215766
Recommendation
2018 updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout
Free

Pascal Richette, Michael Doherty, Eliseo Pascual, Victoria Barskova, Fabio Becce, Johann castaneda, Malcolm Coyfish, Sylvie Guillo, Tim Jansen, Hein Janssens, Frédéric Lioté, Christian D Mallen, George Nuki, Fernando Perez-Ruiz, José Pimentao, Leonardo Punzi, Anthony Pywell, Alexander K So, Anne-Kathrin Tausche, Till Uhlig, Jakub Zavada, Weiya Zhang, Florence Tubach, Thomas Bardin

doi: 10.1136/annrheumdis-2019-215315

June 01, 2019

Correspondence
Can biomarkers differentiate psoriatic arthritis from osteoarthritis?
Free

Jian Tian, Chao Cheng, Fangjie Zhang

doi: 10.1136/annrheumdis-2019-215745

May 31, 2019

Correspondence
Association of proton pump inhibitors with fracture risk in patients with rheumatoid arthritis
Free

Toshihiro Sugiyama

doi: 10.1136/annrheumdis-2019-215747

May 29, 2019

Correspondence
Analysis of IL-6 measurement in patients with GCA treated with tocilizumab should consider concomitant treatment with prednisone
Free

Maxime Samson, Bernard Bonnotte

doi: 10.1136/annrheumdis-2019-215697
Correspondence response
Longitudinal versus cross-sectional IL-6 measurements in tocilizumab-treated GCA response to: ‘Analysis of IL-6 measurement in GCA patients treated with tocilizumab should consider concomitant treatment with prednisone’ by Samson et al
Free

Christoph T Berger, Thomas Daikeler

doi: 10.1136/annrheumdis-2019-215729
Correspondence
Influence of changes in cholesterol levels and disease activity on the 10 years cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients
Free

Marco Fornaro, Fabio Cacciapaglia, Vincenzo Venerito, Giuseppe Lopalco, Florenzo Iannone

doi: 10.1136/annrheumdis-2019-215715

May 24, 2019

Correspondence
SLE-DAS: ready for routine use?
Free

Anoop Mathew, Kavadichanda G Chengappa, Sanket Shah, Vir Singh Negi

doi: 10.1136/annrheumdis-2019-215704
Correspondence
2019 update of the EULAR recommendations for the management of SLE: don’t forget chloroquine
Free

Gabriel Figueroa-Parra, Carmen Magdalena Gamboa-Alonso, Ana Laura De-Leon-Ibarra, Dionicio Angel Galarza-Delgado

doi: 10.1136/annrheumdis-2019-215716

May 22, 2019

Correspondence response
Disease activity and organ damage: different sides of the same coin in systemic sclerosis
Free

Mandana Nikpour On behalf of the Scleroderma Clinical Trials Consortium Damage Index (SCTC-DI) Working Group

doi: 10.1136/annrheumdis-2019-215639
Correspondence
Differentiating disease activity from damage in systemic sclerosis: it’s still early days!
Free

Siddharth Jain, Shefali Khanna Sharma

doi: 10.1136/annrheumdis-2019-215588
Correspondence
Mycophenolate mofetil: a step forward in the induction treatment of ANCA-associated vasculitis? Comment on the article by Jones et al
Free

Frédéric Alain Vandergheynst, Christophe Lelubre

doi: 10.1136/annrheumdis-2019-215647

May 17, 2019

Correspondence
Interosseous tendon inflammation of rheumatoid arthritis: what's the real meaning?
Free

Zhenhan Deng, Haifeng Liu, Wei Lu

doi: 10.1136/annrheumdis-2019-215559
Correspondence response
Response to: ‘Interosseous tendon inflammation of rheumatoid arthritis: what's the real meaning?’ by Deng et al
Free

Kulveer Mankia, Maria-Antonietta D'Agostino, Jorge Murillo-González, Andrew Grainger, Paul Emery

doi: 10.1136/annrheumdis-2019-215611

May 16, 2019

Correspondence
Response to: ‘Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis’ by Sabbagh et al
Free

Zaixing Yang, Yan Liang

doi: 10.1136/annrheumdis-2019-215678
Correspondence response
Response to: ‘Blood plasma versus serum: which is right for sampling circulating membrane microvesicles in human subjects?’ by Liu et al
Free

Yasuhiro Kato, JeongHoon Park, Hyota Takamatsu, Atsushi Kumanogoh

doi: 10.1136/annrheumdis-2019-215540

May 15, 2019

Correspondence response
Response to ‘Decision making value of nuclear dense fine speckled pattern in systemic autoimmune rheumatic disease: trick or treat?’ by Deng et al
Free

Luis Eduardo Coelho Andrade, Jan Damoiseaux, Edward K Chan

doi: 10.1136/annrheumdis-2019-215640
Correspondence
Decision-making value of nuclear dense fine speckled pattern in systemic autoimmune rheumatic disease: trick or treat?
Free

Chuiwen Deng, Xiaohui Qu, Shaoyun Cheng, Xiaofeng Zeng, Yongzhe Li, Yunyun Fei

doi: 10.1136/annrheumdis-2019-215587

May 14, 2019

Correspondence response
Response to: ‘The utility of the HEp-2000 antinuclear antibody substrate’ by Lee et al
Free

Jan Damoiseaux, Edward K Chan

doi: 10.1136/annrheumdis-2019-215610
Correspondence
Utility of the HEp-2000 antinuclear antibody substrate
Free

Adrian Y S Lee, Dimitra Beroukas, Peter J Roberts-Thomson

doi: 10.1136/annrheumdis-2019-215519
Correspondence
Comorbidity and long-term outcome in patients with congenital heart block and their siblings exposed to Ro/SSA autoantibodies in utero
Free

Hasan Satış, Reyhan Bilici Salman, Aslihan Avanoğlu Güler, Hazan Karadeniz, Şeyma Yıldız, Neslihan Kayahan

doi: 10.1136/annrheumdis-2019-215542

May 10, 2019

Correspondence
How to use the Lupus Low Disease Activity State (LLDAS) in clinical trials
Free

Ioannis Parodis, Mandana Nikpour

doi: 10.1136/annrheumdis-2019-215650
Correspondence response
Response to ‘Antinuclear antibodies by indirect immunofluorescence and solid phase assays’ by Bossuyt et al
Free

David S Pisetsky, Diane M Spencer, Peter E Lipsky, Brad H Rovin

doi: 10.1136/annrheumdis-2019-215479
Correspondence
Antinuclear antibodies by indirect immunofluorescence and solid phase assays
Free

Xavier Bossuyt, Jolien Claessens, Ellen De Langhe, Thibaut Belmondo, Rene Westhovens, Sophie Hue, Koen Poesen, Daniel Blockmans, Michael Mahler, Marvin J Fritzler

doi: 10.1136/annrheumdis-2019-215443

May 09, 2019

Correspondence
TARA study: a new perspective on tapering drugs in RA
Free

Debashish Mishra, Arghya Chattopadhyay, Sanjay Jain, Varun Dhir

doi: 10.1136/annrheumdis-2019-215594

Log in using your username and password

Main menu

Log in using your username and password

You are here

Online First

July 04, 2019

July 03, 2019

June 27, 2019

June 22, 2019

June 21, 2019

June 19, 2019

June 18, 2019

June 17, 2019

June 14, 2019

June 12, 2019

June 08, 2019

June 05, 2019

June 01, 2019

May 31, 2019

May 29, 2019

May 24, 2019

May 22, 2019

May 17, 2019

May 16, 2019

May 15, 2019

May 14, 2019

May 10, 2019

May 09, 2019

Pages